Hearing Review·Industry news·Business & finance·7w agoCilcare Updates License Agreement with Sanofi, Brings Pharma Giant on as Equity HolderSanofi's deepened investment in Cilcare's hearing-loss pipeline reflects growing pharmaceutical industry confidence that drug-based treatments for hearing loss are commercially viable.
Hearing Health Matters·Press release·Business & finance·8w agoSanofi Takes Equity Stake in Cilcare as Hearing Therapeutics Partnership ExpandsA major pharma player deepening its financial commitment to hearing therapeutics signals growing industry confidence that drug-based treatments for hearing loss may reach the clinic within the coming years.＋Save
